Long-term, off-label treatment with fenofibrate significantly reduces liver damage markers and improves prognostic scores in primary biliary cholangitis (PBC) patients who do not respond…
News
A genetic susceptibility to gestational diabetes mellitus (GDM), a common pregnancy complication marked by intolerance to blood sugar due to low levels of the insulin…
FATTY LIVER DISEASE
NewsNew ALF board chair turned personal loss from MASH into public advocacy
David Frank, who lost his mother to a severe form of steatotic liver disease and has since become a strong liver health advocate, is…
BILIARY ATRESIA
NewsBreastmilk helps babies recover after Kasai surgery, study shows
Children with biliary atresia who undergo standard Kasai surgery to restore bile flow tend to grow better and have healthier livers when they receive…
The European Medicines Agency (EMA) has started its formal review of bepirovirsen, a move that could introduce a new class of therapy for adults with…
April is officially recognized in the U.S. as National Donate Life Month, an opportunity to highlight the extraordinary impact of organ donation, and the…
CHOLESTASIS
NewsInflammation markers may predict fetal risk in ICP: Study
Blood levels of certain pro-inflammatory proteins are elevated in people with intrahepatic cholestasis of pregnancy (ICP), and these inflammatory markers may help predict the…
FATTY LIVER DISEASE
NewsHeavy episodic drinking raises odds of liver scarring in MASLD patients
People with metabolic dysfunction-associated steatotic liver disease (MASLD) who drink heavily at least once a month face higher odds of advanced liver scarring than…
HEPATITIS
NewsTreating hepatitis C in jails seen as key to stopping spread
Offering jail-based hepatitis C programs that include testing, treatment, and post-release support could cut new hepatitis C virus (HCV) infections in half among people…
An artificial intelligence (AI) tool that analyzes patterns in blood molecules may help distinguish people with primary sclerosing cholangitis (PSC) and inflammatory bowel disease…
Recent Posts
- FDA gives bepirovirsen priority review for chronic hepatitis B
- Starting disease marker levels may shape Iqirvo response in PBC
- The possibility for liver function to improve brings me hope
- New mouse model could help guide PFIC3 treatment research
- “Zombie” immune cells may help drive steatotic liver disease, study shows